Quantitative phosphoproteomics of proteasome inhibition in multiple myeloma cells.

Quantitative phosphoproteomics of proteasome inhibition in multiple myeloma cells.

The proteasome inhibitor bortezomib represents an important advance in the treatment of multiple myeloma (MM). Bortezomib inhibits the activity of the 26S proteasome and induces cell death in a variety of tumor cells; however, the mechanism of cytotoxicity is not well understood. We investigated the...

Full description

Bibliographic Details
Main Authors: Feng Ge, Chuan-Le Xiao, Li-Jun Bi, Sheng-Ce Tao, Sheng Xiong, Xin-Feng Yin, Li-Ping Li, Chun-Hua Lu, Hai-Tao Jia, Qing-Yu He
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-09-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20927383/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20927383/?tool=EBI

Similar Items